Recombinant Human VAP-1 Protein, CF 3957-AO-010: R&D Systems
Effects of an anti-inflammatory VAP-1/SSAO inhibitor, PXS-4728A, on pulmonary neutrophil migration | Respiratory Research | Full Text
Vascular adhesion protein-1 (VAP-1) in vascular inflammatory diseases: A narrative review: Vasa: Vol 51, No 6
VAP-1 and CD73, Endothelial Cell Surface Enzymes in Leukocyte Extravasation | Arteriosclerosis, Thrombosis, and Vascular Biology
Hypercholesterolemia of obese mice with deletion of vascular adhesion protein-1 occurs without other atherosclerosis risk factor
Inhibition of vascular adhesion protein-1 modifies hepatic steatosis in vitro and in vivo
A working model for VAP-1 function in the leukocyte extravasation... | Download Scientific Diagram
Vascular Adhesion Protein-1: A Cell Surface Amine Oxidase in Translation | Antioxidants & Redox Signaling
Vascular adhesion protein-1 enhances neutrophil infiltration by generation of hydrogen peroxide in renal ischemia/reperfusion in
PXS-4681A, a Potent and Selective Mechanism-Based Inhibitor of SSAO/VAP-1 with Anti-Inflammatory Effects In Vivo | Journal of Pharmacology and Experimental Therapeutics
Frontiers | Vascular Adhesion Protein-1 (VAP-1)/Semicarbazide-Sensitive Amine Oxidase (SSAO): A Potential Therapeutic Target for Atherosclerotic Cardiovascular Diseases
VAP-1 and CD73, Endothelial Cell Surface Enzymes in Leukocyte Extravasation | Arteriosclerosis, Thrombosis, and Vascular Biology
PXS-4681A, a Potent and Selective Mechanism-Based Inhibitor of SSAO/VAP-1 with Anti-Inflammatory Effects In Vivo | Journal of Pharmacology and Experimental Therapeutics
Frontiers | Circulating Vascular Adhesion Protein-1 Level Predicts the Risk of Cardiovascular Events and Mortality in Hemodialysis Patients
Vascular adhesion protein-1 (VAP-1) in vascular inflammatory diseases: A narrative review: Vasa: Vol 51, No 6